Molecular mechanisms and design principles for promiscuous inhibitors to avoid drug resistance: lessons learned from HIV-1 protease inhibition.
Molecular mechanisms and design principles for promiscuous inhibitors to avoid drug resistance: lessons learned from HIV-1 protease inhibition.
复制标题
混杂抑制剂避免耐药性的分子机制和设计原则：从 HIV-1 蛋白酶抑制中吸取的教训。
DOI：
10.1002/prot.24730
复制
发表时间：
2015
期刊：
影响因子：
2.9
通讯作者：
Tidor,Bruce
中科院分区：
文献类型：
--
作者：
Shen,Yang;Radhakrishnan,MalaL;Tidor,Bruce
Molecular recognition is central to biology and ranges from highly selective to broadly promiscuous. The ability to modulate specificity at will is particularly important for drug development, and discovery of mechanisms contributing to binding specificity is crucial for our basic understanding of biology and for applications in health care. In this study, we used computational molecular design to create a large dataset of diverse small molecules with a range of binding specificities. We then performed structural, energetic, and statistical analysis on the dataset to study molecular mechanisms of achieving specificity goals. The work was done in the context of HIV‐1 protease inhibition and the molecular designs targeted a panel of wild‐type and drug‐resistant mutant HIV‐1 protease structures. The analysis focused on mechanisms for promiscuous binding to bind robustly even to resistance mutants. Broadly binding inhibitors tended to be smaller in size, more flexible in chemical structure, and more hydrophobic in nature compared to highly selective ones. Furthermore, structural and energetic analyses illustrated mechanisms by which flexible inhibitors achieved binding; we found ligand conformational adaptation near mutation sites and structural plasticity in targets through torsional flips of asymmetric functional groups to form alternative, compensatory packing interactions or hydrogen bonds. As no inhibitor bound to all variants, we designed small cocktails of inhibitors to do so and discovered that they often jointly covered the target set through mechanistic complementarity. Furthermore, using structural plasticity observed in experiments, and potentially in simulations, is suggested to be a viable means of designing adaptive inhibitors that are promiscuous binders. Proteins 2015; 83:351–372. © 2014 Wiley Periodicals, Inc.
登录
查看更多内容
影响因子：
4.8
作者：
G. Francis;R. Parks;J. Cohn
通讯作者：
G. Francis;R. Parks;J. Cohn
多巴胺同源物异波巴胺在充血性心力衰竭中的作用
影响因子：
3
作者：
J. Ren;D. V. Unverferth;C. Leier
通讯作者：
C. Leier
通过选择性 DA1 拮抗剂 SCH 23390 分离外周多巴胺受体。
DOI：
10.1161/01.hyp.6.2_pt_2.i25
发表时间：
1984
期刊：
Hypertension (Dallas, Tex. : 1979)
影响因子：
--
作者：
Goldberg,LI;Glock,D;Kohli,JD;Barnett,A
通讯作者：
Barnett,A
DOI：
10.1056/nejm198405243102105
发表时间：
1984-05
期刊：
The New England journal of medicine
影响因子：
--
作者：
S. Rajfer;A. Anton;J. Rossen;L. Goldberg
通讯作者：
S. Rajfer;A. Anton;J. Rossen;L. Goldberg
溴隐亭治疗洋地黄引起的室性快速心律失常：犬模型研究。
影响因子：
24
作者：
A. Kao;J. Kriett;H. Tobler;B. L. Detloff;M. Pritzker;D. Benson;D. Benditt
通讯作者：
D. Benditt